How we measure. How we prescribe. How we publish what we find.
Every member receives the same panel at intake and every quarter thereafter. Markers grouped by the system they map to, not by the convenience of the lab vendor.
Plain-English logic, not a black box. Every decision is reviewed and signed by a licensed physician before it reaches your dashboard.
Group your markers by system. Flag values outside age-corrected reference range.
Map flagged systems to candidate protocol families. Rule out contraindications first.
Order candidate compounds by evidence grade, legal status, and your personal history.
Your physician of record reviews, modifies if needed, and signs the protocol.
We grade A through D. Editorial control sits with the Medical Director; version history is public.
Multiple RCTs or meta-analyses. Mechanism + outcomes well-characterized.
Smaller RCTs or robust observational. Mechanism plausible, outcomes consistent.
Animal or small human data. Reasoned but unproven at scale.
Anecdotal or first-in-human only. We do not prescribe at this grade.

Aggregate, anonymized cohort outcomes, released every quarter with methodology footnotes. No cherry-picked testimonials.




Three doors. Same rigor underneath.